AI assistant
Lite Strategy, Inc. — Director's Dealing 2021
May 5, 2021
34267_dirs_2021-05-05_00a15bd6-09e2-44f9-b40c-f8e2ab7b767b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2021-04-30
Reporting Person: GHALIE RICHARD G (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17123 | Direct |
| Restricted Stock Units | 20000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.21 | 2026-03-07 | Common Stock (130000) | Direct | |
| Stock Option (Right to Buy) | $1.38 | 2026-07-14 | Common Stock (25000) | Direct | |
| Stock Option (Right to Buy) | $2.88 | 2027-07-07 | Common Stock (65000) | Direct | |
| Stock Option (Right to Buy) | $4.28 | 2028-07-12 | Common Stock (130000) | Direct | |
| Stock Option (Right to Buy) | $2.52 | 2029-07-01 | Common Stock (150000) | Direct | |
| Stock Option (Right to Buy) | $3.49 | 2030-07-02 | Common Stock (150000) | Direct |
Footnotes
F1: 20,000 restricted stock units vest on July 2, 2022.
F2: All options are currently exercisable.
F3: 1/4th of shares vest one-year from July 7, 2017, with the remaining balance of shares vesting in 36 equal amounts over three years.
F4: 1/4th of shares vest one-year from July 12, 2018, with the remaining balance of shares vesting in 36 equal amounts over three years.
F5: 1/4th of shares vest one-year from July 1, 2019, with the remaining balance of shares vesting in 36 equal amounts over three years.
F6: 1/4th of shares vest one-year from July 2, 2020, with the remaining balance of shares vesting in 36 equal amounts over three years.